AU Patent

AU2023332216A1 — Treatment of fasciolosis

Assigned to Intervet International BV · Expires 2025-02-20 · 1y expired

What this patent protects

The present invention relates to compounds and compositions of Formula (I) for treating a fasciolosis in a mammal.

USPTO Abstract

The present invention relates to compounds and compositions of Formula (I) for treating a fasciolosis in a mammal.

Drugs covered by this patent

Xdemvy (LOTILANER) · Tarsus

Patent Metadata

Patent number: AU2023332216A1
Jurisdiction: AU
Classification: —
Expires: 2025-02-20
Drug substance claim: No
Drug product claim: No
Assignee: Intervet International BV
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.